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Abstract: Diflubenzuron and teflubenzuron are benzoylureas that are used in aquaculture to control 39 
sea lice. Flubenzurons have low toxicity to many marine species such as fish and algae, but by their 40 
nature are likely to have significant adverse effects on non-target species such as crustaceans and 41 
amphipods. Although the exact mechanism of toxicity is not known, these compounds are thought to 42 
inhibit the production of the enzyme chitin synthase during moulting of immature stages of 43 
arthropods. These chitin synthesis inhibitors are effective against the larval and pre-adult life stages 44 
of sea lice. Due to their low solubility and results of recent monitoring studies conducted in Norway, 45 
the sediment compartment is considered the most likely reservoir for these compounds and possible 46 
remobilization from the sediment to benthic crustaceans could be of importance. For this reason, the 47 
epibenthic copepod, Tisbe battagliai, was selected for use in the investigations into acute and 48 
developmental effects of these compounds. For comparative purposes, azamethiphos was 49 
investigated to identify differences in sensitivity and act as a negative control for developmental 50 
effects at environmentally relevant concentrations. Standard acute studies with adult copepods 51 
showed little or no acute toxicity at mg/L levels with the flubenzurons, while a naupliar 52 
developmental test demonstrated that environmentally relevant concentrations (e.g. ng/L) caused a 53 
complete cessation of moulting and finally death in the exposed copepods. 54 
Keywords: Tisbe battagliai, Diflubenzuron, Teflubenzuron, Azamethiphos, Naupliar development 55 
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INTRODUCTION 57 
Aquaculture in Norway has been in existence as far back as 1850, when brown trout were 58 
first reared. The modern aquaculture industry in Norway started around 1970 after the construction 59 
of the first seawater cages [1], which proved more successful than the land based/onshore tanks that 60 
were used previously. Now the aquaculture industry in Norway is one of the most important 61 
industries in coastal areas and Norway’s largest export after oil and gas, specifically commercial 62 
Atlantic salmon (Salmo salar L.). The latest figures from the Norwegian Seafood Council show record 63 
values for Norwegian salmon exports, with the value for the first half of 2013 totalling NOK 17.4 64 
billion (ca. €2.1 billion) [2]. 65 
As the aquaculture industry is so important economically, possible threats, such as parasitic 66 
infections from sea lice (Copepoda, Caligidae), especially Lepeophtheirus salmonis and Celigus spp. 67 
are important to control. Medicinal products have been employed in the aquaculture industry to 68 
tackle the issue of sea lice infestation in farmed salmon since the 1980s [3]. In Norway, several 69 
products are regularly employed against sea lice. For example diflubenzuron (DIF) and teflubenzuron 70 
(TEF) which are benzoylurea medicines administered in fish food. On the Norwegian market they are 71 
sold as Releeze vet. (0.6 g/kg DIF) and Ektoban vet. (2 g/kg TEF). In the late 1990s these two products 72 
were in use, but by the end of the 1990s a voluntary ban was introduced due to the suspected 73 
adverse environmental impacts of these products [4]. However, in recent years the use of these 74 
products has again increased due to the resistance of the sea lice to the flubenzuron replacement 75 
product emamectin benzoate [5]. From 2010 to 2011 the use of flubenzurons sharply decreased, 76 
however in 2012 their usage was back up to the 2010 levels. Recently, it has also been reported that 77 
the use of TEF and DIF have doubled both from 2011 to 2012 and again from 2012 to 2013 [6]. In the 78 
past two years, there have been two different reports [4, 7] showing the negative impacts of 79 
flubenzurons on various crustaceans. Therefore the recent increase in their use in the aquaculture 80 
industry in Norway is potentially a very serious environmental situation.  81 
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Another important veterinary medicine used in salmon farming in Norway is azamethiphos 82 
(AZA) (market name Salmosan) which is a broad spectrum organophosphorus insecticide used 83 
against flies and other arthropods in agriculture as well as sea lice in salmon farming. Unlike the 84 
flubenzuron products, AZA is applied topically through bath treatments (with an application rate of 85 
0.1 - 0.2 mg/L). The use of AZA as a potential delousing agent for salmon lice was first reported by 86 
Roth and Richards [8]. The safety of azamethiphos has previously been evaluated for the 87 
establishment of Maximum Residue Limits (MRLs) in Salmonidae and the conclusion was that no 88 
MRLs were required for the protection of consumer safety as the measured residues in salmon 89 
muscle and skin were always below the limit of detection (LOD) even one hour after treatment [9]. 90 
The inclusion of AZA in this study was based on the reported usage of the various delousing 91 
treatments used in Norway over the past few years. As the possible risks to non-target species and 92 
possible persistence of the flubenzurons became of more interest, the use of AZA was seen to 93 
increase in the period of 2008-2011, when the use of the flubenzurons decreased (Table 1). All three 94 
compounds are widely used in salmon aquaculture in Norway at present and are of fundamental 95 
importance to the Norwegian aquaculture market but also specifically to the environment.  96 
The Ministry of Fisheries is the main authority responsible for the licensing of new farms and 97 
the control of the industry. In Norway there is mandatory sea lice monitoring, reporting and auditing. 98 
A condition for receiving a licence for aquaculture activities is that the activity does not comprise a 99 
danger for the spreading of fish disease. The management plans for the facility must be approved by 100 
the Animal Health Authority. Records must be kept of disease outbreaks, diagnoses, testing and 101 
treatment and the facility must post public notice of antibiotic use. 102 
The licensing requirements for new medicines in Norway are very strict and comply fully with 103 
EC regulations. The pharmaceuticals for treating salmon lice are approved by the Norwegian 104 
Medicines Agency (NoMA) in accordance with the EU rules for the approval of veterinary medicine 105 
products. The Norwegian Medicines Agency is the national regulatory authority for new and existing 106 
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medicines and is responsible for all areas of medicinal products from production, trials and marketing 107 
to monitoring their use. Only approved veterinarians and fish health biologists are allowed to 108 
prescribe medicines for use on fish. In addition there are also regulations specifying the length of 109 
time necessary between treatments with veterinary products and slaughtering of the fish. The 110 
Norwegian Food Safety Authority is responsible for keeping a record of all pharmaceuticals ordered 111 
for use in the aquaculture industry in Norway.  112 
The benzoylurea pesticides are not very toxic to many marine species such as fish and algae, 113 
but due to their specific mode of action (MOA) they are likely to have adverse effects on non-target 114 
species such as the crustaceans and amphipods in the marine environment [4]. Although the exact 115 
mechanism of toxicity is not known, these compounds are thought to inhibit the expression of the 116 
enzyme chitin synthase during moulting in immature stages of arthropod development. These chitin 117 
synthesis inhibitors are therefore effective against the larval and pre-adult life stages of sea lice. The 118 
life cycle of sea lice have been extensively researched [10] and is characterized by 3 distinct 119 
morphological life stages (naupliar, copepodid and chalimus). The number of moults per life stage 120 
can vary between species of sea lice but the free living stage is generally characterized by 2 naupliar 121 
stages and the infective copepod stages [10]. Following attachment to the host fish, the sea lice 122 
moult into a number of chalimus stages before becoming adult.  123 
 Due to the relatively low solubility of the flubenzuron compounds (9.4 and 89 µg/L 124 
for TEF and DIF respectively), they are administered to the fish via the food and consequently 125 
uneaten food and faeces are expected to be the main routes into the environment. In combination 126 
with previous monitoring studies conducted recently in Norway [4], it was concluded that the 127 
sediment is the most likely reservoir for these compounds and that possible remobilization from the 128 
sediment to benthic living crustaceans could be of ecological importance. For this reason, the 129 
epibenthic copepod Tisbe battagliai was selected to investigate the developmental effects of these 130 
compounds to a non-target species. T. battagliai is a sexually reproducing marine harpacticoid 131 
copepod commonly used in the ecotoxicological assessment of chemicals and pollutants. 132 
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Harpacticoids are members of the benthic fauna with a few planktonic species living in close 133 
association with other organisms. They often represent the second largest meiofaunal group in 134 
marine sediments after nematodes [11]. Therefore, they are highly representative of non-target 135 
species that may be exposed in and around fish farms treated with veterinary medicines. 136 
Development through the six naupliar stages to the copepodite stage C1 typically occurs within 96 h 137 
under optimal conditions (e.g. food quality and quantity, temperature etc. [12]). At 20 °C the 138 
development to adult (C6) takes approximately 10 days with the first brood appearing at 139 
approximately day 14 [13]. This short development time from nauplii to adult indicate its suitability 140 
for use in a short term sensitive developmental test for purported endocrine disrupting chemicals 141 
that may affect normal copepod development (e.g. chitin synthesis inhibitors such as the 142 
flubenzurons or moulting disruptors such as fenoxycarb). However, there are currently no existing 143 
standardized regulatory test guidelines for developmental or reproductive studies with this 144 
organism.  145 
Harpacticoids are widespread and are an important food source for macroinvertebrates and 146 
fish. T. battagliai is a benthic copepod and harpacticoid copepods are often one of the most 147 
dominant taxa in marine sediments [14], increasing their relevance as a test species for the 148 
investigation of the effects of TEF and DIF. In addition, the sea lice, like T. battagliai, are also 149 
members of the class Maxillopoda and subclass copepod, therefore they show similarities in their 150 
development and lifecycle. Based on the MOA of the TEF and DIF, they are likely to affect the non-151 
target organism T. battagliai in a similar fashion to the main target organisms the sea lice. Figure 1 152 
and Figure 2 describe the lifecycles of Lepeophtheirus salmonis (a problematic target species in 153 
Norwegian aquaculture) and the test species T. battagliai, respectively.  154 
Due to the way in which these two compounds (DIF and TEF) are administered together in 155 
fish farms in Norway, it is also of great importance that there is an understanding of potential 156 
mixture effects in the marine environment and at the sediment water interface. For comparison 157 
purposes, AZA was also assessed for acute toxicity and developmental effects with T. battagliai. 158 
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However, due to its mode of action, it was predicted that at sub-lethal concentrations it would be 159 
expected to have little effect on moulting and development. The selection of a developmental test 160 
for use with T. battagliai was based on the need to assess possible chronic or developmental effects 161 
of the chitin inhibiting flubenzurons (and the organophosphate pesticide azamethiphos) and to test 162 
the hypothesis that non-target copepods could be affected in the same manner as the target sea lice 163 
at environmentally relevant concentrations. The specific aims of the present study were (1) to look at 164 
individual and mixture toxicity of TEF and DIF and AZA, (2) to develop an early stage naupliar 165 
developmental test to investigate the sublethal toxic effects of flubenzurons and AZA on naupliar 166 
growth and ecdysis and (3) make recommendations on improvements in study design and ease of 167 
use, as well as contribute to the regulatory decision framework regarding the continued use of these 168 
pesticides.  169 
MATERIALS AND METHODS 170 
Test chemicals 171 
The benzoylurea medicines, teflubenzuron (TEF) (CAS Registry No. 83121-18-0) and 172 
diflubenzuron (DIF) (CAS Registry No. 35367-38-5) were obtained from Sigma-Aldrich Norway As. The 173 
organophosphate medicine, azamethiphos (AZA) (CAS Registry No. 35575-96-3) was also obtained 174 
from Sigma-Aldrich Norway As. The organic solvent dimethyl sulphoxide (DMSO) was used as a 175 
solubilizing agent in the preparation of stock solutions of the benzoylurea compounds. Due to the 176 
higher solubility of azamethiphos no solvent was required in the preparation of the stock solutions. 177 
Chemical analysis was conducted on the DMSO stocks for both TEF and DIF using LC/MS/MS analysis 178 
to confirm the starting concentration of each test chemical [4].  179 
 180 
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Acute toxicity of veterinary medicines to T. battagliai 181 
All testing with T. battagliai was conducted with in house cultures. The acute toxicity testing 182 
of all three test chemicals were conducted with slight modifications according to the ISO method 183 
[15]. Toxicity tests were conducted with copepodids 6 ± 2 days old and with nauplii ≤ 3 h old. The 184 
copepodid and naupliar tests were conducted in 12 well polystyrene plates (NUNC) and 48 well 185 
polystyrene plates (NUNC) respectively. Four replicates, each containing 5 animals, were used with a 186 
total of 20 animals per exposure concentration. All tests were incubated in a temperature controlled 187 
room at 20 ± 2 °C and with a 16:8 h light:dark photoperiod. The lethality of each test chemical at 188 
each concentration was recorded and the percentage mortality (LC50, lethal concentration of 50% of 189 
the sample population) compared to the control was calculated after 24 and 48 h. Mortality is 190 
defined as no swimming or appendage movements within an observation period of 10 seconds. At 191 
test initiation and termination dissolved oxygen (DO), salinity and pH were measured to ensure 192 
validity of the test. Measurements of these physico-chemical parameters were measured in the 193 
controls, lowest and highest test concentrations. Seawater used in all testing was approximately 34 194 
‰ and was obtained from the outer Oslofjord at a depth of ca.60 m. 195 
 196 
Optimisation of naupliar development test with T. battagliai 197 
After initial acute toxicity determination with both copepodid and naupliar stages of 198 
T battagliai, the optimization of a naupliar development test was conducted.  199 
The optimization trials included the use of various plates (12, 24 and 96 well polystyrene cell 200 
culture plates), different feeding levels of the marine alga Rhodomonas baltica, and the use of 201 
different renewal periods during a selected 7 day exposure period. For the final study design a 7 day 202 
exposure period was selected to reflect a similar, environmentally relevant exposure scenario for the 203 
organisms, based on the method of dosing of flubenzurons in Norwegian fish farms [4]. All trials were 204 
conducted with natural filtered seawater in the absence of test chemicals at a salinity of ca. 34 ‰. 205 
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Under optimal conditions, T. battagliai should pass through 5 naupliar stages and become copepodid 206 
within 4 days, therefore, this time was used as the criteria for optimization of performance of the T. 207 
battagliai in the various test designs. T. battagliai used in the trials were of a similar age as those to 208 
be used in the definitive studies, ≤ 3 h old. 209 
The Optimal food levels were assessed based on the survival and time to copepodid of 210 
unexposed nauplii. The suitability of test plates and exposure volumes were assessed using survival 211 
and general health as endpoints as well as developmental time.  212 
 213 
Developmental effects of veterinary medicines to T. battagliai 214 
Based on the optimization experiments a suitable test design for a 7 day naupliar 215 
development study was selected, as follows. The selected test plates were 24 well polystyrene cell 216 
culture plates (NUNC) with 2 mL of medium per cell well. T. battagliai ≤ 3 h old were individually 217 
housed in 10 replicates per test concentration. Animals of the correct age were isolate by removing 218 
ten gravid females from in house cultures several days before test initiation. These gravid females 219 
were housed individually in approximately 5 mL of clean seawater containing food. Observations on 220 
released offspring were made at hourly intervals until sufficient nauplii ≤ 3 h old could be collected 221 
for use in the tests. 222 
The animals were fed only once during the experiment and there was no requirement to 223 
renew the medium during the exposure period. The food was prepared from a confluent healthy 224 
culture of R. baltica that was settled for several days prior to test initiation. Once the R. baltica had 225 
settled, the supernatant was poured off and the remaining algae resuspended in a minimum amount 226 
of filtered seawater, mixed and a cell count was made using a Neubauer Improved (Bright-light) 227 
chamber. Based on the total cell count a concentration of 2 x 105 cells/mL was fed to all test 228 
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concentrations, controls and solvent controls. In order to reduce any dilution of the test compounds 229 
once dispensed into the exposure wells, the R. baltica feed was prepared and spiked directly into 230 
each of the test concentrations during preparation, prior to dispensing 2 mL per exposure well.   231 
Observations of mortality and developmental stage were made daily during the 7 day 232 
exposure period. Time to copepodid and development rate were calculated for each individually 233 
housed organism and the total number and percentage of copepods at the end of the study were 234 
calculated per concentration and compared to the controls.  235 
 236 
Biological data analysis 237 
 All data (individual development rate, total number of copepods after 7 days, mortality and 238 
EC values for total number of copepodids at day 7) were statistically evaluated with the commercial 239 
software programme GraphPad Prism 6 for Windows and the EC values were calculated using the 240 
Excel Macro REGtox. All calculations were performed using nominal concentrations.  241 
Data for total number of copepodids after 7 days (numbers summed over all replicates within 242 
a treatment) were analysed using Fischer’s Exact Test for 2 x 2 contingency tables. An overall 243 
significance level of p = 0.05 was used. Mortality data (based on survivors) was assessed in the same 244 
way for Day 7.  245 
Individual development rates were calculated for each surviving organism. The development 246 
rate is the reciprocal of the time to copepodid (reciprocal of the day number (day on which the 247 
organism was copepodid) minus 0.5) and represents that proportion of naupliar development, which 248 
takes place per day in the exposure system.  249 
Statistical procedures were then used to look for significant differences in individual 250 
development rates. In summary, data were tested for normality and homogeneity of variance prior 251 
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to the use of a parametric (ANOVA followed by Dunnet’s post hoc test) or non-parametric (Kruskal 252 
Wallis followed by Dunn’s post hoc test) procedures to identify significant differences between 253 
treatments.  254 
 255 
RESULTS 256 
Acute toxicity of the veterinary medicines to T. battagliai 257 
The measured concentrations of the stocks used in all experiments were 1.5 mg/mL and 1.8 258 
mg/mL for TEF and DIF respectively. At test termination for all acute studies, the DO concentrations 259 
were greater than 4 mg/L at all measured concentrations. Salinity and pH were within ± 2 ‰ or ± 1 260 
unit, respectively, throughout the tests. Control mortality for all acute tests was less than 10 % and 261 
therefore all validity requirements for the standard ISO method were met.  262 
The acute 48 h study with AZA and copepodids (as per ISO 14669) resulted in an LC10 and 263 
LC50 (and corresponding 95 % confidence intervals) of 3.6 (2.6 – 4.5) µg/L and 7.7 (6.8 – 8.5) µg/L. 264 
The same test with nauplii ≤ 3 h old at the start of the test, gave similar results of 3.4 (2.4 – 5.3) µg/L 265 
and 6.7 (5.9 – 7.3) µg/L respectively for the LC10 and LC50 values. Therefore based on these results a 266 
range for the developmental study from 0.225 to 3.6 µg/L was selected.  267 
For the flubenzuron compounds the acute data showed no effects up to 1000 µg/L for both 268 
nauplii and copepodids with DIF. For the TEF acute studies there was no effect up to 1000 µg/L for 269 
the copepodid however, the naupliar acute study with TEF proved more sensitive resulting in 24 and 270 
48 h LC50 values of 230 (58 – 931) µg/L and 40 (4.8 - 419) µg/L. For acute studies with TEF and DIF a 271 
limit of 1000 µg/L was used as the highest concentration. Even at these levels there is little 272 
environmental relevance or realism about the concentrations used but it was deemed unnecessary 273 
to test any higher as effects on other organisms have been observed at lower levels than those 274 
tested in our experiments [16, 17]. In addition, these compounds are highly insoluble and are unlikely 275 
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to occur in the environment in excess of these levels and are more likely to be found at ng/L levels in 276 
marine waters [18].  277 
 278 
Optimisation of naupliar development test with T. battagliai 279 
 For the optimization of the test design for the naupliar developmental study, several 280 
approaches were used. No test chemical was used in the study design experiments. Instead filtered 281 
seawater, as would be employed as a negative control, was used for all experimental trials. The initial 282 
proposed trial was based on the acute study test design, conducted in 12 well tissue culture plates 283 
with a volume of ca. 5 mL per replicate. Ten individually housed animals per test concentration were 284 
used instead of 4 replicates containing 5 animals, this was proposed so that individual development 285 
could be tracked. After trialling a lower and higher feeding level, the final selected level for all trials 286 
was based on previously published data (2 x 10 5 algal cells/mL Rhodomonas baltica) an optimal food 287 
level for development [13, 19] of T. battagliai. Trials were performed for an initial 96 h, after which 288 
time at optimal conditions all nauplii should become copepodid.  289 
Due to the small size of the animals and the large volume of solution in the wells of the 12 290 
well plates, it was difficult to find and assess the animals during the 96 h period. Originally the test 291 
design also planned to incorporate an assessment of moulting on a daily basis. The assessment of 292 
moulting proved difficult and not all moults could be accounted for within the wells. In addition, 293 
within 96 h, under optimal conditions, they would have passed through all naupliar stages potentially 294 
moulting more than once a day, therefore this observation was removed from the study design as 295 
having limited value. In the 12 well test design with individually housed nauplii the survival was 100 296 
% and all test organisms had developed to copepodid within the 4 days. The study was extended to 7 297 
days to assess the need for renewal, during an extended exposure duration in the presence of a test 298 
compound. The animals survived the 7 days and it was concluded that in this case there was no need 299 
to renew the test medium. However, due to the large well size and volume of test medium (ca. 5 300 
15 
 
mL), it was time consuming to assess the animals, which were often found around the rim of the 301 
wells, where visualization with the aid of a microscope proved difficult. It was therefore concluded 302 
that the use of 12 well plates was not optimal for the assessment of naupliar development.  303 
In the second experimental design, an assessment with 96 well plates was trialled. Due to the 304 
size of the test organisms at the start of the test (≤ 3 h) and the small well size, it was possible to 305 
assess the animals easily on a daily basis. The 96 well test design used ten individually housed 306 
animals per test concentration. Each replicate well contained 200 µL of test medium containing algal 307 
feed. This design was to incorporate a renewal period (on day 4) based on the small sample volume 308 
and the hypothesis that there would not be enough surface area for sufficient gas exchange. Daily 309 
observations were made and mortality, behaviour and any moults were observed. By day 3 the 310 
animals were recorded as being in a poor condition. As T. battagliai are epibenthic they are often 311 
observed on the bottom of the test wells. In the case of the 96 well test design the algae introduced 312 
to the wells had quickly settled out on the small surface area on the bottom of the wells, where the 313 
nauplii had become entangled. After 96 h there were no copepodids present, and after a further 24 h 314 
all animals were dead. During the daily observations it did not appear that the animals were grazing, 315 
instead they remained stationary, with movement only after gentle agitation. Another issue with the 316 
96 well test design was generating sufficient volume at test termination for any required physico-317 
chemical analysis.  318 
 The final trial involved 24 well tissue plates containing 2 mL of test solution per replicate. All 319 
other parameters were consistent with the previous two trials, feeding, medium (filtered seawater), 320 
replication etc. No renewal was used in this trial. All animals were copepodid after 96 h and there 321 
was only 10 % mortality (1 death) after 7 days. Therefore the use of the 24 well plates and all other 322 
described parameters were used for the investigation of developmental effect of veterinary 323 
pesticides to T. battagliai.  324 
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 325 
Developmental effects of veterinary medicines to T. battagliai 326 
For the 7 day developmental effects investigations there were four testing scenarios using 327 
the previously described 24 well test design: teflubenzuron only, diflubenzuron only, a 2:1 mixture of 328 
teflubenzuron and diflubenzuron and azamethiphos only.  329 
For all studies the DO, pH and salinity remained within acceptable limits and the survival in all 330 
control and solvent controls was acceptable (≤ 10%).  331 
 332 
Mortality data 333 
The mortality data (day 7) were assessed and the acute NOEC and LOEC for 7 day mortality 334 
for TEF were 0.0032 and 0.01 µg/L respectively. For DIF and the 2:1 TEF:DIF mixture the NOEC and 335 
LOEC were 0.01 and 0.032 µg/L respectively. After 7 days exposure to AZA there was only 10 % 336 
mortality at 3.6 µg/L, this was not statistically significant, therefore the LOEC was > 3.6 µg/L.  337 
 338 
Total number of copepodids 339 
The total number of copepodids on day 7 were compared to the control numbers for the four 340 
different testing scenarios as per the mortality data. For TEF, significant differences in the number of 341 
copepodids by day 7 was found between the control and 0.01 µg/L. It was not necessary to 342 
statistically assess higher concentrations as there were significant mortalities at all concentrations 343 
including 0.01 µg/L and above. Therefore, based on total number of copepods by day 7 the NOEC and 344 
LOEC were 0.0032 and 0.01 µg/L respectively. For DIF, the NOEC and LOEC were 0.01 and 0.032 µg/L 345 
respectively. For the 2:1 mixture, the NOEC and LOEC for total number of copepodids were the same 346 
as for DIF, i.e. 0.01 and 0.032 µg/L. There were no statistically significant differences found for total 347 
number of copepodids up to and including 3.6 µg/L for AZA. 348 
 349 
Developmental rates 350 
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For individual development rates of each surviving animal (based on the day they were 351 
recorded as copepodid) the data was assessed as previously describe. There were no statistically 352 
significant differences in the individual development at any of the tested concentrations of AZA. For 353 
TEF, the development rate of the individuals that successfully became copepodid was not 354 
significantly different to the controls up to 0.0032 µg/L and at concentrations above this there were 355 
either significant effects on the number of copepodids or on the number of mortalities (as described 356 
previously). For DIF, the same was observed. At concentrations up to and including 0.032 µg/L, there 357 
were no significant differences in individual development rates, however there were significant 358 
differences in mortalities and number of copepodids by day 7 as previously described. The same 359 
effect on individual development rate was observed with the 2:1 mixture, where all animals reached 360 
copepodid at the same rate as the controls, however other endpoints such as mortality and number 361 
of animals to reach the copepodid stage showed significant differences at low concentrations (Figure 362 
3).  363 
 364 
Summary of NOECs/LOECs 365 
Time to copepodid, development rate, mortality and the total number of copepodids after 7 366 
days exposure for all test scenarios are shown in Table 2. The overall NOEC/LOEC for the 367 
developmental studies based on the most sensitive endpoints are 0.0032/0.01 µg/L (TEF, endpoints: 368 
mortality and total number of copepodids at day 7), 0.01/0.032 µg/L (DIF, endpoints: mortality and 369 
total number of copepodids at day 7), 0.01/0.032 µg/L (TEF:DIF, endpoints: mortality and total 370 
number of copepodids at day 7). There was no effect compared to the control with any 371 
concentration up to and including 3.6 µg/L for AZA with any endpoint.  372 
DISCUSSION 373 
 The chitin synthesis inhibiting benzoylurea pesticides, teflubenzuron and diflubenzuron and 374 
the organophosphate pesticide azamethiphos were all assayed with acute and developmental 375 
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studies with the non-target marine copepod, T. battagliai. The benzoylureas and azamethiphos were 376 
selected due to their usage patterns in Norwegian aquaculture as well as the fact that they have 377 
different methods for treatment (to the target organism) and different modes of action. TEF and DIF 378 
are administered in fish feed, while AZA is applied as a bath treatment. TEF and DIF act by inhibiting 379 
chitin synthesis in arthropods and AZA acts by the inhibition of cholinesterase activity. Based on 380 
these points it was possible to hypothesis that TEF and DIF would be the most toxic in the 381 
developmental assay and that although AZA may be acutely toxic [20, 21], it would be unlikely to 382 
cause the same developmental effects as with the benzoylurea pesticides. This hypothesis is based 383 
on the specific MOA of the benzoylurea pesticides that are specifically targeting organisms that 384 
require chitin to develop through several stages to adult hood. Both the target organism (the sea 385 
lice) and the non-target organism (T. battagliai) have similar lifecycles (Figure 1 and 2) and require 386 
chitin in order to develop through several morphologically different life stages. Chitin inhibiting 387 
chemicals may affect the moulting activity of these species by halting the process completely, by 388 
retarding the process or by leaving the animals vulnerable to predation between moults. AZA on the 389 
other hand is not likely to have an increased effect on T. battagliai development and was included to 390 
act as a negative control (although acutely toxic) for developmental effects at environmentally 391 
relevant levels in order to highlight the risk to specific groups of organisms through the increased use 392 
of the flubenzuron pesticides.  393 
As indicated previously, both TEF and DIF are applied in fish farms via the feed. The main 394 
challenge with the treatment methodology is that a large amount of food will remain uneaten, Chen 395 
et al. [22] estimated between 5-15 % of the administered food will be uneaten, and approx. 90% of 396 
administered DIF and TEF will be excreted in the faeces [4]. DIF and TEF have low water solubility (89 397 
µg/L and 9.4 µg/L respectively) and are relatively hydrophobic (Log Kow of 3.8 and 5.4 respectively) 398 
and may therefore bind to particles and end up in the sediment. Due to its epibenthic nature, T. 399 
battagliai is a relevant test species to assess the environmental hazard of these test substances 400 
within the sediment as it is present at the sediment water interface and may be exposed to both 401 
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water soluble and particle bound contaminants. Due to limited amounts of data on DIF, the UK 402 
environment agency does not have sediment Environmental Quality Standards (EQS) for this 403 
substance. The Norwegian Environment Agency, is at present evaluating proposed sediment, water 404 
and biota EQS values for both TEF and DIF [23]. The proposed EQSsediment = 0.2 µg/kg for DIF and 405 
0.0004 µg/kg for TEF. Although our study focused on the assessment of toxicological effects to non-406 
target species through water only exposure systems, it is important to consider the risk to sediment 407 
dwelling arthropods that may be affected in the same way as T. battagliai. The report of Langford et 408 
al. [18] measured sediment concentrations of TEF and DIF as high as 269.2 and 136.6 ng/kg 409 
respectively in the sediments around treated fish farms. The measured levels of TEF are in excess of 410 
the new proposed sediment EQS values for Norway (EQSsediment =0.4 ng/kg) but not for DIF (EQSsediment 411 
= 200 ng/kg). Therefore, there is a significant risk to organisms present in or on the sediment that 412 
may be affected through the flubenzurons specific MOA of chitin synthesis inhibition.  413 
 In general, there is limited published ecotoxicity data on developmental and chronic effects 414 
of benzoylurea pesticides on non-target species, especially data on marine organisms [18]. However, 415 
in recent years several organizations have attempted to address the lack of data [7]. This is 416 
particularly relevant in light of the recent resistance of sea lice to the commonly used emamectin 417 
benzoate and the increased use of other aquaculture medicines such as the flubenzurons. Some 418 
acute data for AZA exists and studies with lobster and mysid shrimp have yielded LC50 values of 1.39 419 
µg/L (48 h) [24] and 0.52 µg/L (96 h) [25] while other species such as scallops and clams were 420 
unaffected by AZA [26]. Therefore, from the results of the present study T. battagliai seems to show 421 
a higher tolerance to AZA compared to other crustaceans.  422 
Coppen and Jepson [27] described TEF as being more potent and toxicologically active than 423 
DIF. This is apparent from the results of the present study where we have directly compared the two 424 
pesticides, in both an acute and chronic test system, in which TEF consistently results as the more 425 
toxic of the two. Surprisingly the toxicity observed with the 2:1 TEF:DIF mixture (reflecting treatment 426 
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with both medicines in Norwegian fish farms) elicited the same toxicological effects as DIF and not 427 
TEF despite the TEF being present at a higher concentration in the mixture. As both TEF and DIF have 428 
the same MOA, it has been suggested that the most likely description of the additive hazards from 429 
these 2 chemicals will be concentration addition. In addition it has been suggested that testing of 430 
mixtures of veterinary medicines should be conducted as though the organisms were exposed to 431 
each compound independently. This is due to the fact that the active ingredients would normally not 432 
be placed in the same product, if they compete for the same receptor target (i.e. have the same 433 
MOA). Therefore, the chances of increased sensitivity to aquatic organisms due to a mixture effect, is 434 
unlikely in the case of TEF and DIF [28]. As the mixture of the two chemicals was not more sensitive 435 
than the results of the TEF alone, an assessment factor (AF) for the risk assessment purposes could 436 
be applied to the NOEC from the TEF only developmental study. This would therefore be protective 437 
of any potential mixture effects in the environment. 438 
 Recently published monitoring data for TEF and DIF from in and around fish farms in Norway 439 
[18], treated with both TEF and DIF in combination and DIF alone, have shown elevated levels 440 
present in seawater above the UK Environmental Quality Standards (EQS). Specific UK marine water 441 
EQS values used for the assessment of the monitoring data where 5 ng/L (AA-EQS (Annual Average-442 
EQS)) and 100 ng/L (MAC-EQS (Maximum allowable concentration-EQS)) for DIF and 6 ng/L (AA-EQS) 443 
and 30 ng/L (MAC-EQS) for TEF. The levels measured during the monitoring programme were in the 444 
range of 34.3 – 295.2 ng/L (DIF) and < 1 – 12.9 ng/L (TEF), at the site treated with both DIF and TEF, 445 
and 13.1 – 30.9 ng/L (DIF) for the site treated with DIF alone. These measured environmental levels 446 
are higher than the developmental effect levels observed in the present study. The lowest effect 447 
concentrations (LOEC) for T. battagliai development (number of copepodids on day 7) and mortality 448 
were 10 ng/L and 32 ng/L for TEF and DIF respectively. Therefore it can be concluded that there is a 449 
risk to non-target species in and around the areas treated with these pesticides. The recently 450 
suggested environmental quality standards for sediments, water and biota (submitted to the 451 
Norwegian Environment Agency) [23] propose EQSseawater values for TEF and DIF as follows. For DIF an 452 
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AA-EQS and MAC-EQS of 4 ng/L and 100 ng/L respectively have been suggested and for TEF an AA-453 
EQS and MAC-EQS of 2.5 ng/L and 12 ng/L have been put forward. These EQS values have only been 454 
proposed to the Norwegian Environment Agency and have not officially been adopted by Norway.  455 
With the specific MOA of flubenzurons it is important to consider the acute to chronic ratio 456 
of these substances when performing environmental risk assessments. Flubenzurons elicit their 457 
effect via chitin synthetase. Although chitin synthesis is not functionally part of the endocrine 458 
system, enzyme systems that regulate chitin synthesis are sensitive to chemical alternation by 459 
pesticides like teflubenzuron and diflubenzuron. Therefore they can be considered to be similar to 460 
endocrine disruptors which specifically affect arthropods (and possibly other chitin producing 461 
organisms). Endocrine disruptors typically have a very high acute to chronic ratio indicating that 462 
although acute effects may not be seen at relatively high levels (e.g. mg/L concentrations) sub lethal 463 
(chronic endpoints) can be observed at concentrations significantly lower (e.g. ng/L concentrations). 464 
Historically, a large number of environmental risk assessments have involved estimating chronic 465 
toxicity data from acute toxicity data using an assessment factor. Typically, the assessment factor has 466 
been 100 resulting in a predicted chronic toxicity of 100 times lower than the LC/EC50. From a more 467 
conservative point of view, some risk assessors have applied an assessment factor of 1000 which may 468 
be considered more protective for the environment for substances with non-endocrine mediated 469 
toxicity. For example, in terms of AZA which has been assessed in the present paper, the acute 470 
toxicity was calculated at a concentration of between 6.7 and 7.7 µg/L dependent on the age of the 471 
organisms. In addition, the chronic toxicity NOEC was calculated as 3.6 µg/L. This would mean that 472 
the acute to chronic ratio is only a factor of 2 and by using an assessment factor based on the acute 473 
toxicity data alone would have provided adequate protection for T. battagliai. However, considering 474 
the flubenzurons assessed within the present study and specifically the most toxic (TEF) the acute to 475 
chronic ratio is significantly higher than the assessment factor approach would have predicted the 476 
chronic toxicity. For example, the acute toxicity value for TEF was >1000 µg/L and the NOEC was 477 
0.0032 µg/L which results in an acute to chronic ratio >312500.  478 
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As a preliminary risk assessment for both TEF and DIF, a PNEC has been calculated based on 479 
the NOEC values of 0.0032 and 0.01 µg/L respectively from the T. battagliai naupliar developmental 480 
tests. An AF of 10 was applied to both these values to derive the PNEC. Justification for the selection 481 
of this AF is based on an assessment of the sensitivity of the endpoint, existing EQS values and 482 
detection limits for DIF and TEF (1 ng/L, [4]) in water. Therefore, the PNECseawater for TEF and DIF 483 
would be 0.32 and 1.0 ng/L respectively. Comparing these PNEC values with the Measured 484 
Environmental Concentration (MEC) from Langford et al., [18] to derive Risk Quotients (RQ) for TEF 485 
and DIF would indicate that an even higher number of the monitored sites would be in exceedance of 486 
the RQ of 1 than the previous conclusion [18] based on using the existing EQS values.  487 
 488 
RECOMMENDATIONS AND CONCLUSIONS 489 
In recent years, several naupliar developmental studies with marine copepods have been 490 
developed and now exist as ISO draft standards (ISO/DIS 16778 [29], ISO/TC 147/SC 5 N 761 [30]. 491 
These draft standards assess the developmental effects of Acartia tonsa and Nitocra spinipes from 492 
nauplii to copepodid. These studies are approximately the same length as the proposed T. battagliai 493 
method. However, with the latter, the controls should be copepodid by 96 h, therefore the length of 494 
time for the test could be reduced to just 4 days, compared to 6-7 days or 5-6 days for the N. spinipes 495 
and A. tonsa studies. The idea behind extending the T. battagliai test described in the present study, 496 
is to allow for the observation of retardation of development, where the end point may not be that 497 
the animals do not develop, rather that it happens at a slower developmental rate compared to the 498 
control. However, if the aim is to look only at number of copepodids at the point where > 80 % of the 499 
controls have developed to C1, then 96 h is an acceptable time period for the test. In addition, 500 
another benefit of the proposed T. battagliai test is that individual development rate can be tracked, 501 
which is not the main consideration in the aforementioned ISO standards. Possible improvements to 502 
the proposed study design are an increased number of replicates or increased number of test 503 
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concentrations (> 5) although the ease of testing with this study design and the minimal number of 504 
animals required, that still provides a reasonably robust statistical assessment, makes this method 505 
ideal for assessing chronic toxicity in copepods.   506 
In conclusion, the results of the investigations into the acute and toxic effects of the 507 
flubenzurons (DIF and TEF) and AZA have indicated distinctly different effect patterns between the 508 
two types of veterinary medicines. Azamethiphos was acutely toxic to the test organism T. battagliai 509 
as has been previously described in the literature to other crustaceans. However, at lower levels, 510 
there were no observed developmental effects. In contrast, the flubenzurons, displayed little or no 511 
acute toxicity at microgram per litre levels over a period of 48 h and developmental effects were 512 
seen in the nanogram per litre range. The latter reflects the potential for adverse effects at 513 
environmentally relevant concentrations to non-target organisms within the marine environment. 514 
Taking into consideration the extremely high acute to chronic ratio of flubenzurons, underpins the 515 
importance of designing tests appropriately to the specific MOA. If the environmental risk 516 
assessment had been performed on acute toxicity data alone, there would have been a significant 517 
discrepancy in the risk quotient. This may have resulted in flubenzurons not being regulated 518 
appropriately or sufficiently enough within the aquaculture industry and other substances with 519 
similar modes of action should be considered correspondingly for environmental risk assessment 520 
purposes. 521 
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List of Figure legends: 643 
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Figure 1. Lifecycle of Lepeophtheirus salmonis modified from Schram (1993) with adaptations based 645 
on Herme (2013)  646 
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Figure 2 Lifecycle of Tisbe battagliai modified from Hutchinson et al (1999) with adaptations from 648 
Volkmann-Rocco (1972) 649 
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Figure 3. Development rate (± standard deviation) of nauplii (N1) to copepodid (C1) for (a) 651 
Diflubenzuron, (b) Teflubenzuron, (c) TEF:DIF, (d) Azamethiphos. * indicates statistical difference 652 
compared to the control.  653 
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Table 1. Selected products used against sea lice in aquaculture in Norway. (kg of active substance). 
(Source: Mattilsynet 2014) 
Active 
substance 
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
           
Azamethiphos     66 1884 3346 2437 4059 3037 
Diflubenzuron      1413 1839 704 1611 3264 
Teflubanzuron      2028 1080 26 751 1704 
Emamectin 32 37 60 73 81 41 22 105 36 51 
           
 
 
  
Table 2 Summary of Tisbe battagliai development and mortality data for all test compounds  
Concentration 
(µg/l) 
Time to first 
copepod 
(days) 
Mean time to 
first 
copepodid 
(days) 
Number 
copepodid 
(day 7)a 
Mortalities 
Day 7 (%)a 
Mean 
development 
Rate (days-1)b 
TEFLUBENZURON      
Control 3 3.8 10 0 0.314 
Solvent control 3 3.6 10 0 0.337 
0.0032 3 3.9 9 10 0.335 
0.01 5 5 1 80 NA 
0.032 - - 0 90 NA 
0.1 - - 0 100 NA 
0.32 - - 0 100 NA 
DIFLUBENZURON      
Control 4 4.8 9 10 0.239 
Solvent control 5 5.0 9 10 0.222 
0.0032 5 5.1 9 10 0.218 
0.01 5 5.3 8 20 0.189 
0.032 5 5.5 3 70 0.202 
0.1 - - 0 90 NA 
0.32 - - 0 100 NA 
2:1 Mix TEF:DIF      
Control 4 4.4 10 0 0.260 
Solvent control 3 4.2 10 0 0.277 
0.0032 3 4.6 9 10 0.264 
0.01 4 5.1 9 10 0.225 
0.032 5 5.8 4 50 0.195 
0.1 - - 0 50 NA 
0.32 - - 0 90 NA 
AZAMETHIPHOS      
Control 3 3.1 10 0 0.389 
0.225 3 3.4 10 0 0.359 
0.45 3 3.1 10 0 0.389 
0.9 3 3.1 10 0 0.389 
1.8 3 3.2 10 0 0.377 
3.6 3 3.1 9 10 0.387 
b Nominally 10 animals tested per concentration. 
a individual development rate = 1/(day number-0.5). All developmental rates are given to three 
significant figures. 
NA = Not applicable 
 
 
 
